In MLL-rearranged AML, leukemia stem cells (LSCs) are highly dependent on the purine biosynthesis pathway; CRISPR screens show that purine biosynthetic genes are selectively upregulated in LSCs, and MYC-driven purine metabolism maintains LSC stemness and differentiation arrest [17]. The gene discussed is MYC; the disease is acute myeloid leukemia.